➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
McKesson
Colorcon
Baxter
Johnson and Johnson

Last Updated: May 25, 2020

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: CINACALCET HYDROCHLORIDE


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

CINACALCET HYDROCHLORIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Alkem Labs Ltd CINACALCET HYDROCHLORIDE cinacalcet hydrochloride TABLET;ORAL 210570 ANDA American Health Packaging 60687-525-21 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-525-21) > 1 TABLET, FILM COATED in 1 BLISTER PACK (60687-525-11)
Alkem Labs Ltd CINACALCET HYDROCHLORIDE cinacalcet hydrochloride TABLET;ORAL 210570 ANDA Ascend Laboratories, LLC 67877-503-01 100 TABLET, FILM COATED in 1 BOTTLE (67877-503-01)
Alkem Labs Ltd CINACALCET HYDROCHLORIDE cinacalcet hydrochloride TABLET;ORAL 210570 ANDA Ascend Laboratories, LLC 67877-503-30 30 TABLET, FILM COATED in 1 BOTTLE (67877-503-30)
Alkem Labs Ltd CINACALCET HYDROCHLORIDE cinacalcet hydrochloride TABLET;ORAL 210570 ANDA Ascend Laboratories, LLC 67877-503-33 10 BLISTER PACK in 1 CARTON (67877-503-33) > 10 TABLET, FILM COATED in 1 BLISTER PACK
Alkem Labs Ltd CINACALCET HYDROCHLORIDE cinacalcet hydrochloride TABLET;ORAL 210570 ANDA Ascend Laboratories, LLC 67877-504-01 100 TABLET, FILM COATED in 1 BOTTLE (67877-504-01)
Alkem Labs Ltd CINACALCET HYDROCHLORIDE cinacalcet hydrochloride TABLET;ORAL 210570 ANDA Ascend Laboratories, LLC 67877-504-30 30 TABLET, FILM COATED in 1 BOTTLE (67877-504-30)
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
Moodys
Mallinckrodt
McKinsey
AstraZeneca